119 related articles for article (PubMed ID: 17187185)
21. Usefulness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens.
Ocque R; Tochigi N; Ohori NP; Dacic S
Am J Clin Pathol; 2011 Jul; 136(1):81-7. PubMed ID: 21685035
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor.
Gomez-Fernandez C; Mejias A; Walker G; Nadji M
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):137-41. PubMed ID: 19875957
[TBL] [Abstract][Full Text] [Related]
23. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
[TBL] [Abstract][Full Text] [Related]
24. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Bishop JA; Sharma R; Illei PB
Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
[TBL] [Abstract][Full Text] [Related]
25. DC-LAMP stains pulmonary adenocarcinoma with bronchiolar Clara cell differentiation.
Zhu LC; Yim J; Chiriboga L; Cassai ND; Sidhu GS; Moreira AL
Hum Pathol; 2007 Feb; 38(2):260-8. PubMed ID: 17056097
[TBL] [Abstract][Full Text] [Related]
26. G protein-coupled receptor 26 immunoreactivity in intranuclear inclusions associated with polyglutamine and intranuclear inclusion body diseases.
Mori F; Tanji K; Miki Y; Toyoshima Y; Yoshida M; Kakita A; Takahashi H; Utsumi J; Sasaki H; Wakabayashi K
Neuropathology; 2016 Feb; 36(1):50-5. PubMed ID: 26303144
[TBL] [Abstract][Full Text] [Related]
27. Intranuclear inclusions in epithelial cells of benign proliferative breast lesions.
Harada O; Hoe R; Lin J; Thike AA; Jara-Lazaro AR; Petersson F; Tan PH
J Clin Pathol; 2011 Sep; 64(9):776-80. PubMed ID: 21606232
[TBL] [Abstract][Full Text] [Related]
28. Evidence of surfactant protein A and D expression decrement and their localizations in human prostate adenocarcinomas.
Kankavi O; Baykara M; Eren Karanis MI; Bassorgun CI; Ergin H; Ciftcioglu MA
Ren Fail; 2014 Mar; 36(2):258-65. PubMed ID: 24168624
[TBL] [Abstract][Full Text] [Related]
29. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin.
Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS
Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132
[TBL] [Abstract][Full Text] [Related]
30. Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution.
Penman D; Downie I; Roberts F
J Clin Pathol; 2006 Jun; 59(6):663-4. PubMed ID: 16731609
[TBL] [Abstract][Full Text] [Related]
31. Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion.
Kim JH; Kim YS; Choi YD; Lee JS; Park CS
Acta Cytol; 2011; 55(3):266-70. PubMed ID: 21525739
[TBL] [Abstract][Full Text] [Related]
32. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.
Fukuoka J; Fujii T; Shih JH; Dracheva T; Meerzaman D; Player A; Hong K; Settnek S; Gupta A; Buetow K; Hewitt S; Travis WD; Jen J
Clin Cancer Res; 2004 Jul; 10(13):4314-24. PubMed ID: 15240517
[TBL] [Abstract][Full Text] [Related]
33. Thyroid transcription factor 1: a marker for lung adenoarinoma in body cavity fluids.
Gomez-Fernandez C; Jorda M; Delgado PI; Ganjei-Azar P
Cancer; 2002 Oct; 96(5):289-93. PubMed ID: 12378596
[TBL] [Abstract][Full Text] [Related]
34. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
Kim MJ; Shin HC; Shin KC; Ro JY
Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
[TBL] [Abstract][Full Text] [Related]
35. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
Su YC; Hsu YC; Chai CY
Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563
[TBL] [Abstract][Full Text] [Related]
36. Thyroid Transcription Factor-1 Expression in Adenocarcinomas of the Bile Duct.
Lino-Silva LS; Salcedo-Hernández RA; García-Gómez MA; Ruiz-García EB; Aguilar-Romero JM; Domínguez-Rodríguez JA; Herrera-Gómez Á; Maldonado-Martínez HA
Int J Surg Pathol; 2016 Feb; 24(1):24-8. PubMed ID: 26316052
[TBL] [Abstract][Full Text] [Related]
37. Morphologic and molecular analysis of 39 spontaneous feline pulmonary carcinomas.
D'Costa S; Yoon BI; Kim DY; Motsinger-Reif AA; Williams M; Kim Y
Vet Pathol; 2012 Nov; 49(6):971-8. PubMed ID: 21900542
[TBL] [Abstract][Full Text] [Related]
38. TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.
Rossi G; Marchioni A; Milani M; Scotti R; Foroni M; Cesinaro A; Longo L; Migaldi M; Cavazza A
Am J Clin Pathol; 2004 Dec; 122(6):884-93. PubMed ID: 15595193
[TBL] [Abstract][Full Text] [Related]
39. Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid.
Liu L; Cohen C; Siddiqui MT
Acta Cytol; 2012; 56(4):425-30. PubMed ID: 22846220
[TBL] [Abstract][Full Text] [Related]
40. TTF-1 positivity in 2 cases of adenocarcinoma of the gastrointestinal tract.
Pegolo E; Machin P; Damante G; Di Loreto C
Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):e27-31. PubMed ID: 25247229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
